S100A9 induces acute myeloid leukemia (AML) cell differentiation through TLR4–MAPK/ERK–JNK signaling, whereas S100A8 prevents differentiation induced by S100A9 activity and maintains the AML immature phenotype. This evidence concerns the gene MAPK8 and acute myeloid leukemia.